By using this website you consent to our use of these cookies.
Pharmaceuticals in the environment
Poorly disposed-of medicines can have an impact on the environment. We aim to lead our industry in understanding and limiting the environmental effects of pharmaceuticals in the environment (PIE). As a minimum, we are committed to ensuring effective environmental management of our products from pre-launch through to end-of-life. We work with various organisations, including authorities and stakeholders across the supply chain, to raise public awareness of the safe disposal of medicines; one such example is the EU meds disposal campaign, #medsdisposal.
Our US business is conducting a pilot pressurised metered dose inhaler (pMDI) collection scheme with a major distributor and innovative recycler. Patients will be given the opportunity to return used pMDIs for recovery and recycling of the plastics and metals they contain. The pilot, conducted over the first six months of 2018, will evaluate the overall success of this approach and help shape our future device sustainability strategy.
You are now leaving AstraZeneca.com
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.
Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.
You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.
I have read this warning and will not be using any of the contained product information for clinical purposes.